Skip to Main Content

"Hypersomnia" Joel Oster (05.12.2021)

May 26, 2021

"Hypersomnia" Joel Oster (05.12.2021)

 .
  • 00:06Alright.
  • 00:10Let's see, people are filing in. Perfect.
  • 00:21Alright, well good afternoon everybody.
  • 00:22My name is Andres in truck and thank
  • 00:25you again for joining us for yet
  • 00:27another edition of the joint Yale
  • 00:30Harvard Tufts Sleep Seminars and in
  • 00:32the setting of the Yale Sleep Center,
  • 00:34there occurs at 2:00 PM and
  • 00:37every Wednesday and so today.
  • 00:39We are lucky to hear from
  • 00:41Doctor Auster from Tufts,
  • 00:42will be introduced by Doctor Grover.
  • 00:44But first I just want to take a
  • 00:47moment to ensure that everyone is
  • 00:49muted who is not speaking during the.
  • 00:52Presentation if you are interested
  • 00:54in receiving credit for attendance,
  • 00:55please see the chat room for
  • 00:57instructions and you can text the
  • 00:59unique ID for this conference
  • 01:01anytime between 1:45 PM and 3:15 PM
  • 01:03to receive credit and if you're not
  • 01:05already registered with the DLC Me,
  • 01:07you will have to do that first and
  • 01:09for questions in your presentation,
  • 01:11please make sure to use the chat rooms
  • 01:14throughout the hour and I will help
  • 01:16moderate the discussion just to let
  • 01:18you know that the recorded versions
  • 01:20of these presentations are available
  • 01:21online within a couple of weeks.
  • 01:232 weeks at the link provided in the chat.
  • 01:27So finally,
  • 01:27as usual,
  • 01:28please feel free to share the
  • 01:30announcements for this weekly
  • 01:31lecture series with anyone who
  • 01:33you think might be interested or
  • 01:35have them contact Debbie Lovejoy
  • 01:37to be added to our mailing list.
  • 01:39And so this turns out to be our
  • 01:41last joint conference for the year,
  • 01:43and so we're going to go out with a with
  • 01:46a bang and looking forward to the talk,
  • 01:49and so I will hand the mic over
  • 01:51to Doctor Grover at Tufts.
  • 01:55Hi good afternoon everyone.
  • 01:57It's my pleasure to introduce my colleague,
  • 02:00Doctor Joe Lasker.
  • 02:01Today he's an esteemed colleague
  • 02:04here at Tufts for many years and I'm
  • 02:07it's really great working with him.
  • 02:09It he's one of our adapter Oscar
  • 02:12completed his medical degree from
  • 02:14Boston University School of Medicine.
  • 02:16He then went on to do his residency
  • 02:19at Tufts Medical Center and
  • 02:21followed by a year of fellowship
  • 02:24in Neurology and now Fellowship.
  • 02:27Add mass General Hospital in
  • 02:30epilepsy and e.g enable potentials.
  • 02:32He's he started his career at Leahy
  • 02:36Clinic and he was there for some time
  • 02:40and then he's been a tough since
  • 02:432015 and he is a faculty associate
  • 02:47professor here at Tufts Medical Center.
  • 02:52And he's also in neurology,
  • 02:54and he's the director of e.g.
  • 02:57And the intraop neurophysiology.
  • 03:00A clinic as well and he's,
  • 03:02you know it's a pleasure to have
  • 03:05a neurologist in our sleep center
  • 03:07whose sleep boarded and has been a.
  • 03:10Important part of our fellowship
  • 03:12and and without further ado,
  • 03:14I'd like to introduce Doctor Auster.
  • 03:18Thank you for that very kind introduction
  • 03:20and what an honor and privilege to be
  • 03:23here today to lecture at this joint.
  • 03:25Lecture series. As a.
  • 03:29Individual has primarily been a clinician.
  • 03:32I really leaned on the.
  • 03:34Giants have great researchers,
  • 03:36many of whom may actually be joining the
  • 03:39session from the injunctive faculty.
  • 03:43With this team I mentioned their work in
  • 03:47passing and to make everyone an expert
  • 03:50and maybe even a hypersomnia. Activist,
  • 03:52these patients are very interesting.
  • 03:54They're very challenging.
  • 03:57They deserve our compassion and.
  • 04:01To work with them is often difficult
  • 04:03because of the lack of definitive therapies,
  • 04:06particularly for idiopathic hypersomnia.
  • 04:09And I will touch on those points
  • 04:11throughout the lecture and hopefully
  • 04:13leave you all with the state of the art.
  • 04:16What is known about the general
  • 04:19clinical aspects of hypersomnia?
  • 04:20So in the upper left is a
  • 04:22shot of Tufts Medical Center.
  • 04:24And I Chinatown area Boston and
  • 04:28hypersomnia is a particularly.
  • 04:31Narcolepsy is a tetrad which is due
  • 04:34to inappropriate sleepiness and
  • 04:36then the other features that are
  • 04:38the ancillary symptoms such as.
  • 04:40Cataplexy from a strong emotion
  • 04:42sleep paralysis.
  • 04:43And here's my rendition of
  • 04:45neurotransmitters in the brain causing.
  • 04:48Hypnagogic phenomenon,
  • 04:49but I was privileged to work on the
  • 04:52most up-to-date 3rd edition of Netter.
  • 04:54Neurology and this is from the chapter
  • 04:56that myself and my mentor Paul Gross at Co.
  • 04:59Author. This is van Gogh's.
  • 05:04Rendition of Siesta after Malay, I believe.
  • 05:09What struck?
  • 05:11Me was that.
  • 05:12It's somehow inappropriate with the flood of.
  • 05:15Yellow and and and tinged orange shoes.
  • 05:18It seems that this sleep is
  • 05:20somehow inappropriate midday.
  • 05:26Disclosures I cannot.
  • 05:28Co investigator or principal investigator.
  • 05:30Number of epilepsy trials.
  • 05:31None for Sleep Medicine.
  • 05:32I'm like coauthor in two editions of
  • 05:35the Native neurology book I served.
  • 05:37As an advocacy and advocate on the
  • 05:39Epilepsy Foundation of New England.
  • 05:42All my money is going to the institution.
  • 05:46So there is no commercial support and
  • 05:48there are no conflicts of interest.
  • 05:51I will overview the current research that
  • 05:54active on idiopathic hypersomnia and
  • 05:57I'm going to touch on some off label.
  • 06:00Items I'm not advocating for them,
  • 06:02I'm just describing I want people
  • 06:04to understand the breath of.
  • 06:06The current state of the art
  • 06:07with regards to that entity.
  • 06:11So the learning objectives are to give
  • 06:13you a comprehensive review of hypersomnia.
  • 06:16It's under recognized especially
  • 06:17as a primary disorder.
  • 06:19And I'm going to start with the case,
  • 06:21and then I'm going to conclude
  • 06:22with another case of how even
  • 06:24seasons Sleep Medicine experts
  • 06:25fail to recognize it in a patient.
  • 06:27Patients may not be adequately
  • 06:29evaluated for secondary causes.
  • 06:31Anne, this lecture will allow learners
  • 06:32to understand both the neurobiology,
  • 06:34the clinical features of the primary
  • 06:36hypersomnia and those that are secondarily.
  • 06:39'cause a middle ground disorder is epilepsy.
  • 06:41Patients with epilepsy.
  • 06:42There is some debate as to whether
  • 06:45or not the sleep dysfunction and
  • 06:47the sleepiness is part of the
  • 06:49primary disorder or whether it's
  • 06:50secondary due to the nature of the.
  • 06:54Pathways and the neurotransmitters
  • 06:55in the underlying substrate.
  • 06:57The brain.
  • 06:57So the second point is this lecture will
  • 06:59review an overview of the neurobiology
  • 07:01regarding sleep and weight normal substrates,
  • 07:03and I will rely heavily on work of others.
  • 07:06This lecture reviews the mechanisms that
  • 07:08are known in primary and secondary insomnia,
  • 07:11and then I plan to review the actual.
  • 07:15Relevant 8 ASM practice parameters
  • 07:16that are available.
  • 07:17Many of them are quite of 13 or 15 years old.
  • 07:22At this point there is a update up-to-date.
  • 07:27It was an up to date chat that was
  • 07:29generated to to the members to update
  • 07:31some of those practice parameters,
  • 07:32but they're not yet on the site.
  • 07:35And this is particularly relevant because
  • 07:37we will see how idiopathic hypersomnia
  • 07:40entity is evolving in the literature and.
  • 07:43May need to be caught up in our society.
  • 07:47Practice points.
  • 07:48So in Boston we like many other places,
  • 07:51we have a number of higher
  • 07:53centers of higher learning,
  • 07:54and so we now have acquired a an array of
  • 07:57young patients in their late teens and 20s
  • 08:00who suddenly have a problem such as this.
  • 08:03So I will describe a 22 year old
  • 08:05patient who has difficulty staying
  • 08:07awake during college even with
  • 08:09nine hours of sleep at night.
  • 08:11Falls asleep in class at another time,
  • 08:13but notices curiously that he's refreshed
  • 08:16with a very brief 5 to 10 minute nap.
  • 08:19More recently,
  • 08:19he would have to lean against something,
  • 08:21especially if you became emotional
  • 08:23in his legs or he'd have a feeling
  • 08:25that his head might drop.
  • 08:27But sometimes it would be so subtle
  • 08:29that others might not detect it.
  • 08:32He emerges from his naps,
  • 08:33unable to move and awake.
  • 08:35It might see scary images,
  • 08:36but he's paralyzed.
  • 08:37He can't scream.
  • 08:38Can't talk.
  • 08:39Units that,
  • 08:39while he might have had sleepiness
  • 08:41as a youngster while in high
  • 08:43school earlier the symptoms have
  • 08:44become more manifest recently when
  • 08:46he really needs to be awake and
  • 08:48concentrate and do his best the most.
  • 08:50And in one of these colleges.
  • 08:53So Ted Cruz is going to give us a nice
  • 08:56visual of what it looks like to be sleepy.
  • 08:59So you know,
  • 09:00we can see a patient like this
  • 09:02in the neurology clinic,
  • 09:03and the differential might be
  • 09:05myasthenia gravis or weakness.
  • 09:06But this was a this was a state
  • 09:08of the Union address,
  • 09:10where depends on what side
  • 09:11of the aisle you are,
  • 09:13whether this sleeping this was
  • 09:15appropriate or inappropriate,
  • 09:16but excessive daytime sleepiness is
  • 09:17generally an inappropriate response.
  • 09:18That is time poorly to life circumstances.
  • 09:21So based on the international
  • 09:24classification of sleep disorders.
  • 09:25EDS or excessive daytime sleepiness is
  • 09:27excessive when it causes a subjective
  • 09:30complaint or interferes with function.
  • 09:32And its inability to maintain
  • 09:34wakefulness and alertness during the
  • 09:36major waking episodes of the day
  • 09:38with sleep occurring inappropriately.
  • 09:40Hypersomnia and hypersomnolence.
  • 09:41No,
  • 09:41it's just someone who's just a minor nuances,
  • 09:44but it's used these these terms are
  • 09:46using to tame interchangeably when.
  • 09:48Sleepiness occurs that's inappropriate.
  • 09:50When wakefulness is expected,
  • 09:52and hypersomnia is as a disorder is
  • 09:55characterized by hypersomnolence.
  • 09:56Fatigue is everything else.
  • 09:58So there are cytokines.
  • 10:00Inflammatory processes,
  • 10:01their psychiatric processes with
  • 10:03fatigue is the subjective lack of
  • 10:06physical and mental energy with
  • 10:08a broad differential diagnosis.
  • 10:09In the past, stimulants and sedatives,
  • 10:12awake and asleep, was a binary enterprise.
  • 10:15However,
  • 10:16we learn from some of the great
  • 10:19science behind,
  • 10:20such as from Clifford Saper's lab
  • 10:22and and others that sleep maybe
  • 10:24a continuum where it's a dimmer
  • 10:27switch and
  • 10:27the primary hypersomnia is
  • 10:30particularly narcolepsy involved.
  • 10:32A loose dimmer switch where there is a
  • 10:35continuum of promotion of wakefulness
  • 10:37versus promotion of sleepiness.
  • 10:40And this talk will show you some of the
  • 10:43biological substrates to give you much
  • 10:45more rationality behind that analogy.
  • 10:48So sleep is a requisite for
  • 10:50optimal function mune system.
  • 10:51The cardiac cardiac muscle
  • 10:53requires it to rest,
  • 10:54and optimal optimally function and model
  • 10:57and remodel memories consolidate at night.
  • 10:59This pruning of the neurons and
  • 11:01sprouting and numerous processes that
  • 11:04occur verified by clinical studies
  • 11:06and observation and sleep deck
  • 11:08may be sub optimal to ones health,
  • 11:10and it relates to the need for sleep
  • 11:13which will talk about from some of the
  • 11:16epidemiology belie wise and others.
  • 11:18With characterized how that changes
  • 11:20throughout the lifespan and sleep
  • 11:22deprivation causes a physiological rebound
  • 11:24in sleep patterns in a certain manner.
  • 11:27And then primary secondary
  • 11:28causes by alluded to May Co.
  • 11:31Mingle with other disorders.
  • 11:33So the epidemiology of hypersomnia
  • 11:36pathological sleepiness is
  • 11:37a major cause of mobility.
  • 11:39Job loss, poor attention,
  • 11:41impacts driving focus,
  • 11:42focus,
  • 11:42social functioning and really a
  • 11:45non quantifiable societal cost.
  • 11:46The prevalence varies in the literature up
  • 11:49to 25% in US to one and 3300 or one in 5000.
  • 11:54In the United States.
  • 11:56And it may actually vary
  • 11:59throughout the lifespan,
  • 12:00particularly in in women,
  • 12:02excessively daytime sleepiness has been
  • 12:04reported to decrease in age in some studies,
  • 12:07and there is a general equal gender ratio
  • 12:11or female predominant up to two to one.
  • 12:14For women who developed excessive daytime
  • 12:17sleepiness and meet in a 10 year period,
  • 12:19that's an 8% to EDS development.
  • 12:228% of women.
  • 12:23The strongest independent risk factors
  • 12:25were insomnia, smoking and then,
  • 12:27less important, more anxiety,
  • 12:28depression, somatic symptoms,
  • 12:29snoring, and obesity.
  • 12:31But depression and we sleep architecture.
  • 12:33In the neural pathways.
  • 12:35That immediately by depression
  • 12:36you'll see layers later in the
  • 12:39talk are sharing somewhat of the
  • 12:41same neurobiology and circuitry.
  • 12:43So this is a an article that
  • 12:45highlights how total sleep time
  • 12:47changes naps wake after sleep onset,
  • 12:50me altering women throughout the lifespan.
  • 12:5420,000 patients have narcolepsy United
  • 12:56States and about 3,000,000 worldwide.
  • 12:58This is an estimate.
  • 12:59It's the number one cause of
  • 13:01sleepiness in the United States.
  • 13:04Is not narcolepsy success, it's OSA.
  • 13:07Narcolepsy is number 2.
  • 13:09Approximately 5% of patients in
  • 13:10the sleep center have a primary
  • 13:12narcolepsy diagnosis,
  • 13:13with comorbid occurrence with a number
  • 13:15of other primary sleep disorders.
  • 13:181/4 of patients with narcolepsy have OSA.
  • 13:21The prevalence of narcolepsy is
  • 13:2220 to 67 per 100,000 worldwide
  • 13:24and it occurs most often.
  • 13:26The second decade of life.
  • 13:27Although the patient I showed you.
  • 13:30In attack in the early 3rd Decade of life,
  • 13:33but the diagnosis is often delayed,
  • 13:34as in this case.
  • 13:36This is from the Seminole Paper
  • 13:38that's on the practice parameter
  • 13:40of how to manage one of the two
  • 13:43Seminole Papers on the ASM website.
  • 13:45Back in 20.
  • 13:46Oh seven.
  • 13:47There were 13 primary sleep
  • 13:49disorders that are.
  • 13:51Identified in the category of hypersomnia.
  • 13:55If you go on the hypersomnia foundation.org
  • 13:58website which mentions the ICS D3,
  • 14:00which is the most current classification
  • 14:02of sleep disorders, there are eight.
  • 14:05These include narcolepsy type,
  • 14:06one with cataplexy, narcolepsy Type
  • 14:082 which doesn't have cataplexy.
  • 14:11Idiopathic hypersomnia, which people
  • 14:12wonder if it's not collapse E Type 3.
  • 14:15But many of those patients
  • 14:18biologically heavy.
  • 14:19May have a normal hypocretin level,
  • 14:20so is it really just an alteration of
  • 14:23different part of the pathway or not?
  • 14:26Let's talk.
  • 14:26I'm not going to spend a lot of time if
  • 14:29at all inclined to live in syndrome,
  • 14:32which is a truly remains an enigma
  • 14:34with these periods of hypersomnolence
  • 14:35and hyperphagia hypersomnia
  • 14:37due to medical condition,
  • 14:38hypersomnia do a substance.
  • 14:40Psychiatric condition and insufficient sleep.
  • 14:43Up to date you'll have a slightly different
  • 14:46category if you subscribe to that,
  • 14:48they break it down in in this way.
  • 14:52We use the Epworth scale to
  • 14:54quantify level of sleepiness.
  • 14:55Is a validated scale that allows
  • 14:57you to really distill out from a
  • 15:00patient's history that they're
  • 15:01sleeping from a neurologic 'cause
  • 15:03they're not depressed they don't have.
  • 15:06Athenia they don't have tiredness
  • 15:08from from an inflammatory state.
  • 15:09The normal level of sleepiness
  • 15:11is a score less than 10.
  • 15:13The maximum on these eight questions
  • 15:15is 24 patients who have sleep
  • 15:17apnea are often in the 11:50 range.
  • 15:19In those patients that are narcoleptic,
  • 15:21not not collect tix or really
  • 15:23pathologically sleepy.
  • 15:24Or 15 and above.
  • 15:25We are not a good observer of when we
  • 15:28have seizures and when we have states
  • 15:31of partial awareness and when we're sleepy.
  • 15:348 is borderline, but anything less
  • 15:36than 8 to 10 is considered normal.
  • 15:38Getting a good night's sleep
  • 15:39across the lifespan.
  • 15:40The need varies from infancy to old age and
  • 15:43for adults they can get by on less sleep,
  • 15:45but they're not at their best cognitively
  • 15:47unless you get the requisite amount,
  • 15:49so it needs to be continuous and have normal
  • 15:51architecture and should contain all elements,
  • 15:53including REM and slow wave.
  • 15:54Yet patients who come to
  • 15:56the sleep lab we often see.
  • 15:58Reduced percentages of some
  • 16:00of these entities,
  • 16:01especially if they're an SSRI's
  • 16:03that suppress these.
  • 16:05And.
  • 16:06Some what is a pseudo science behind
  • 16:09how significant that may or may not be?
  • 16:11Why incremental knowledge is
  • 16:13accumulated to why goodnight sleep
  • 16:14is important across the lifespan?
  • 16:16This is a very nice article from
  • 16:19Max Herskowitz who I believe
  • 16:21started out of Tufts before he had
  • 16:24a super illustrious career.
  • 16:26All,
  • 16:27and this is a very nice article that
  • 16:29shows that Wausau increases over
  • 16:31time and there's a decrease in RAM,
  • 16:33slow wave and an increase in stage one.
  • 16:36We think that stage one in Wausau.
  • 16:39At least according to the blog Wise
  • 16:41and and and that School of Epidemiology
  • 16:44represents sleep instability.
  • 16:45And at the ASM last June,
  • 16:48which is virtual, a lot of those lectures,
  • 16:51particularly by Doctor Masci,
  • 16:53indicated that some patients
  • 16:55with pathological
  • 16:56sleepiness from a hypersomnia
  • 16:57might have more. Stage one,
  • 16:59and Wausau sleep has to be organized
  • 17:02so that we have a coordinated
  • 17:04endocrine and body response so that
  • 17:06we can be at our best physiologically
  • 17:09from a number of different plans.
  • 17:12This is Doctor Robert Mccarley
  • 17:14had the privilege to know.
  • 17:16He partially the adenosine
  • 17:18hypothesis and he is one of the
  • 17:22most cited individuals for for the.
  • 17:24Findings in schizophrenia with the
  • 17:26morphometry of the superior temporal gyrus.
  • 17:29But he also discovered portions of
  • 17:31the ram nucleus many decades ago,
  • 17:34and he also observed that adenosine in
  • 17:36the basil forebrain rose incrementally
  • 17:38while awake and therefore was believed
  • 17:41to be responsible to increasing
  • 17:43levels of sleepiness after being
  • 17:45awake and with higher concentrations,
  • 17:47it may actually inhibit arousal
  • 17:49cause sleepiness.
  • 17:50Anna decreases during sleep in that.
  • 17:53Off my coffee is a noncompetitive
  • 17:56antagonist of adenosine at the receptor.
  • 17:58The adenosine receptor biology is known
  • 18:01as it interacts with producing and Dom
  • 18:04endogenous antigen from prostaglandins.
  • 18:06An adenosine is either stored in a release
  • 18:09and start to be formed inside of cells.
  • 18:12Or or possibly on the surface and
  • 18:14and its proposed as a modulator,
  • 18:16it may cause some days of dilate
  • 18:18by basil dilation.
  • 18:19The weakness of this theory, however.
  • 18:21Although it's observed,
  • 18:23you know there's no patient that we
  • 18:26prescribe enough Red Bull and coffee
  • 18:28to mitigate the effects of hypersomnia,
  • 18:31and this molecule doesn't really interact
  • 18:33with the known neurobiology of the circuitry,
  • 18:36such as at the ereckson receptor,
  • 18:39the heterodimers formation,
  • 18:40the VLP,
  • 18:41all which initiates sleep onset,
  • 18:43and the other pathways.
  • 18:44So it may be an epiphenomenon,
  • 18:47but it hasn't really led to a major
  • 18:50insider inroad into those.
  • 18:52Neuronal connectivity pathways,
  • 18:53but adenosine is on the left.
  • 18:56Caffeine is on the right.
  • 18:58These these articles written.
  • 19:02About 20 plus years ago are or more are very,
  • 19:08very interesting.
  • 19:09So hypersomnia we know results when
  • 19:11sleep at night is inefficient,
  • 19:13fragmented or normal.
  • 19:14Sleep architecture is disturbed
  • 19:16at secondary or there's an
  • 19:17intrinsic problem for this.
  • 19:18And how do we evaluate this complaint?
  • 19:21Well,
  • 19:21I put this type of slide up because
  • 19:23there's nothing more gratifying to
  • 19:25a sleep Doctor Who sees a lot of
  • 19:28OSA patients to see RAM rebound.
  • 19:30So this was a patient who suddenly
  • 19:31had a very organized process after he
  • 19:34came in for a second night after a
  • 19:36diagnostic sleep study or polysomnogram
  • 19:38where there was a very good.
  • 19:40REM, rebound and we all felt good.
  • 19:43Wow, what a success.
  • 19:44This patient had continuous sleep until
  • 19:46the helipad landed and caused him to wake up.
  • 19:49And then he went back to sleep
  • 19:51and lo and behold,
  • 19:52the patient was able to maintain sleep.
  • 19:55But narcolepsy has a sleep wake instability.
  • 19:57An ram may intrude into the waking state.
  • 20:00Now this is what we see as the sort
  • 20:03of gospel on the ASM where this
  • 20:05is the MSL T where we are right
  • 20:08now when I'm giving my lecture at
  • 20:11two or three in the afternoon,
  • 20:13we have the greatest tendency to be
  • 20:15falling asleep on MSL T with the
  • 20:18sleep homeostatic drive or the OR the.
  • 20:21Homeostatic drive is at its
  • 20:22highest with the lowest of the
  • 20:25circadian alerting sender signal,
  • 20:26so process and process C are
  • 20:28the most fire furthest apart.
  • 20:30It's interesting that with the understanding
  • 20:33of how fragmented sleep isn't,
  • 20:35how incontinent patients are of
  • 20:36their rent peers during the day,
  • 20:39that we really don't have a good diagram
  • 20:41of this for the primary hypersomnia.
  • 20:44So maybe we will in the future,
  • 20:46and this is obviously someone that
  • 20:49got there early evening.
  • 20:51No, I'm ram slow wave sleep such as
  • 20:53you see in fleet recovery and they
  • 20:55got more or increasing periods of REM
  • 20:58throughout the night as the night went on.
  • 21:00But here's a patient on the bottom here.
  • 21:03This hymn of what Naka Lefty looks
  • 21:05like and I would add I got this
  • 21:07online so it's blurry.
  • 21:09I want to give credit words do
  • 21:10but some of our patients they even
  • 21:13have much more sleep onset REM's
  • 21:15during the day than this.
  • 21:16So narcolepsy hypersomnia is a
  • 21:18disease that spans a 24 hour period.
  • 21:20That fragment sleep and fragments
  • 21:22wake in these patients.
  • 21:23I have an unpredictable lifestyle
  • 21:26where neurotransmitters planktonic
  • 21:27roles that wax and wane and sleep
  • 21:29and wake are totally destabilized,
  • 21:31like a very dysfunctional loose
  • 21:34dial on a dimmer switch.
  • 21:37So major neurologic mechanisms
  • 21:38promote wakefulness from the
  • 21:40reticular activating system,
  • 21:41with ascential choline glutamate,
  • 21:42noradrenergic systems and
  • 21:44rim is parallel to that,
  • 21:45and I'll show you more of that
  • 21:48as this lecture proceeds.
  • 21:50And termination phase is not simply.
  • 21:55A switch it's a dialing up of wakefulness
  • 21:58and a dialing down of the sleepiness.
  • 22:02So anything that fragments this process,
  • 22:03such as.
  • 22:04Here's a ramp period where you're paralyzed,
  • 22:06and if you're on your back supine,
  • 22:08you have an airway that's closed
  • 22:10and you have an arousal 'cause you
  • 22:12can't breathe these fragmentations
  • 22:14of your sleep will lead to profound
  • 22:16EDS during the day or excessive
  • 22:18daytime sleepiness.
  • 22:20As an EG I like to show a parallel
  • 22:23between EG and sleep and the brain
  • 22:25from time of life to the time of death
  • 22:28is never offline on the upper left.
  • 22:30This is wakefulness, where you have a post,
  • 22:33your predominant alpha rhythm
  • 22:35reaching 8 to 8 more Hertz.
  • 22:38On the right is drowsiness.
  • 22:40Is that the same isn't in Fenton
  • 22:42Cefal Opathy, where there stay there,
  • 22:44or fragmentation of the alpha.
  • 22:45Sleep is by no means a passive process.
  • 22:48Look at how active these posts
  • 22:50are beginning of stage two.
  • 22:52Stage two is very busy with
  • 22:54spindles and K complexes.
  • 22:55Stajan 3 is not flat,
  • 22:57but it's slow with this delta
  • 22:59and ram it becomes active again
  • 23:01with these eye movements.
  • 23:03And low voltage e.g paraments not
  • 23:05quite like wait but it is fast and
  • 23:08it's mediated by almost the same.
  • 23:10Neurotransmitters,
  • 23:10but in a different location and nuclei
  • 23:12in the brain, which we talk about.
  • 23:14With encephalopathies or up foundation,
  • 23:17the pathways are different.
  • 23:18The classical awake or arousal
  • 23:20system is involved in sleep,
  • 23:22but it also involved in self allopathy.
  • 23:25Is there is a impact of the thalamus
  • 23:27where there is obtundation that
  • 23:29occurs which disrupts that pathway
  • 23:31and in the cases of metabolic ensup
  • 23:34allopathy they may be triphasic waves.
  • 23:37Furthermore, when there's this organ.
  • 23:40Damage or there's Frank.
  • 23:43Quarter to excitability.
  • 23:44Some of these waves actually involve
  • 23:47the hours for other source of the
  • 23:49cortex that involve epilepsy,
  • 23:51and we have a continuum from these long
  • 23:55probability of ictal patterns too.
  • 23:58Suppression versus versa question,
  • 23:59which I'm not showing on this slide.
  • 24:02These triphasic waves and
  • 24:03then epileptiform discharges.
  • 24:04But sleep is a completely
  • 24:07different circuitry.
  • 24:08Here are epileptiform discharges
  • 24:09from her on the bottom panels.
  • 24:11These are continuous here on the left.
  • 24:13These are on one side on the right.
  • 24:16The upper left is the a brain that
  • 24:20has diffuse cortical damage and
  • 24:22is flatline or brain dead and the
  • 24:25upper right shows birth suppression
  • 24:28that's induced by pharmaco therapies
  • 24:31such as propofol or or.
  • 24:35Other senators,
  • 24:36but this is a very different circuitry,
  • 24:38a very different look,
  • 24:39very different pattern,
  • 24:40and a very set of different pathways
  • 24:43other than those that that involve
  • 24:45sleeping wake as a epileptologist.
  • 24:47I would digress.
  • 24:48At this point a little bit to
  • 24:50talk about epilepsy and sleep and
  • 24:52patients with epilepsy or pwe.
  • 24:54There's a high end,
  • 24:56higher incidence of sleep disorders in
  • 24:58this population, with 13% of patients.
  • 25:01Also,
  • 25:01having always say in the moderate to
  • 25:03severe range and the hypoxemia and
  • 25:06arousal that occurs in those patients,
  • 25:08either from their epilepsy or and
  • 25:10often their OSA may cause pseudo or
  • 25:12sudden unexplained death in epilepsy.
  • 25:14But OSA is a very highly treatable entity.
  • 25:18Lack of sleep is one of the most
  • 25:21important triggers of seizures with
  • 25:23a third of patients in particular
  • 25:25who may fly under the radar,
  • 25:27and so you ask the question along
  • 25:30with alcohol, stress medication,
  • 25:32noncompliance, missed doses.
  • 25:34Sleep fragmentation might
  • 25:35actually decrease your TST,
  • 25:36leading to seizures,
  • 25:37total sleep time,
  • 25:38and anything that can lead to the
  • 25:40bus increase seizures.
  • 25:41This is a little rectal discharge where.
  • 25:44The sharp part.
  • 25:45Anything that looks like it
  • 25:47would hurt if you sat on it like
  • 25:49a thumbtack is a sharp you.
  • 25:51After going slow wave may actually be
  • 25:54mostly hyperpolarization protective.
  • 25:55But these are typical interictal
  • 25:57discharges which are seen when the
  • 25:59patient is not having a seizure
  • 26:01and lack of sleep.
  • 26:02Causes an increase of this.
  • 26:04An interactive discharges are distributed
  • 26:06differently in different stages of sleep.
  • 26:08The highest rates are in these rolling
  • 26:10delta waves which are highly synchronous.
  • 26:12So impious traitor and stage in three and
  • 26:14four much more in the stage two in stage one,
  • 26:17it's very rare to have an
  • 26:19interactive discharge in REM
  • 26:21because of the hyper synchrony,
  • 26:22but circadian effects may play a role.
  • 26:25Anne.
  • 26:26Less than 1% of seizures
  • 26:28actually come out of RAM.
  • 26:30The less synchronous the EG,
  • 26:31such as when you're awake, are in REM.
  • 26:34The less likely depolarization
  • 26:35or seizures will occur.
  • 26:37In temporal lobe epilepsy,
  • 26:38there's a tendency for
  • 26:40hours and then a seizure,
  • 26:41and this is usually in the late
  • 26:43afternoon with frontal lobe seizures.
  • 26:45There are often brief events with
  • 26:47tonic motor components out of sleep,
  • 26:49with little to no postictal phase,
  • 26:51and some syndromes are time locked
  • 26:52somehow and we don't understand the
  • 26:54neurobiology for the wait period
  • 26:56such as juvenile myoclonic epilepsy,
  • 26:58where there's a myoclonic jerk or
  • 27:00series of falls in coordination in
  • 27:02the morning with grand Mal epilepsy.
  • 27:04Benign Epileptiform central temple
  • 27:06central temporal epilepsy with
  • 27:07spikes or rolandic seizures are
  • 27:09typically seen in the morning,
  • 27:11yet we have more rain periods in the morning,
  • 27:14so that violates the principle in
  • 27:16a way that that RAM is protective,
  • 27:19but this may be an independent entity,
  • 27:21Landau kleffner,
  • 27:22which is one of the catastrophic seizure
  • 27:24syndromes of childhood catastrophic,
  • 27:26especially if you miss it because
  • 27:28these brains are busy seizing away.
  • 27:31You may have microcephaly,
  • 27:32and when the brain is busy.
  • 27:35Seizing particularly in posterior
  • 27:36temporal area on the left with the
  • 27:38language development areas are.
  • 27:40And these patients have continuous
  • 27:41spike and wave and sleep.
  • 27:43These patients have profile language delays.
  • 27:46But epilepsy patients commonly complain
  • 27:48of EDS with the medication burden.
  • 27:51Many of them are on rescue medications
  • 27:54that are benzodiazepine's.
  • 27:55This significant weight gain that can
  • 27:57lead to OSA and confounding variables.
  • 28:00Depression may also be a comorbid
  • 28:02complication and changes the sleep
  • 28:04architecture and REM density and so
  • 28:06forth and other other other features.
  • 28:09And after daytime seizures is a decrease
  • 28:12in RIM increased in REM latency
  • 28:14and more and one in fragmentation,
  • 28:16probably law so.
  • 28:18Epilepsy itself,
  • 28:19even in the absence of Aedes and OSA,
  • 28:22may cause sleep fragmentation so.
  • 28:24Epilepsy might actually represent
  • 28:25a primary hypersomnia,
  • 28:26but the verdict is out and that's why I
  • 28:29included at the beginning of the talk.
  • 28:31This is a patient of ours that
  • 28:34has a responsive neurostimulator,
  • 28:36and these patients are so refractory
  • 28:38that they are either failed surgery
  • 28:41or they require.
  • 28:44Italian of approach to their care,
  • 28:46so these patients we do neurostimulation
  • 28:47in any part of the pathway where the
  • 28:50discharge is in the most robust,
  • 28:51and this is a patient that not
  • 28:53only has a cyclical pattern.
  • 28:55Of the surrogate marker of irritability,
  • 28:57these these devices.
  • 28:58These many computers delineate in eracle
  • 29:01discharges throughout the day and night.
  • 29:03This patient has up to 3000 them
  • 29:05through the through the day and night,
  • 29:08and this patient can be noted to
  • 29:10have electrographic seizures,
  • 29:11but when we activate these devices,
  • 29:13and this has become accepted in
  • 29:16the literature, there isn't.
  • 29:17It has been evolving literature on this.
  • 29:20You change the distribution of when the
  • 29:22interactive discharges and seizures
  • 29:23and long episodes of those interactive
  • 29:26discharges occur into the night period.
  • 29:28So from 10:00 PM.
  • 29:30To 5:00 AM.
  • 29:31So this is relatively new.
  • 29:32How this impacts sleep tiredness doesn't
  • 29:34ameliorate the sleepiness of epilepsy.
  • 29:36The verdict is yet to be found.
  • 29:38We have about 13 or 14 these
  • 29:40patients at our Medical Center,
  • 29:41and most of them have converted to have their
  • 29:44interactive discharges during the evening,
  • 29:45which is convenient because if you
  • 29:47have a seizure at night in your own
  • 29:50bed rather than at the workplace,
  • 29:51it may actually be beneficial.
  • 29:53But is there a higher risk or not of SUDEP?
  • 29:56But some of those studies are
  • 29:57showing that these devices to improve
  • 29:59student or stunned unexplained,
  • 30:01definitely.
  • 30:02I was very fortunate as I may have
  • 30:05alluded to to Co.
  • 30:06Author with my mentor Paul Gross
  • 30:08and a chapter and the third.
  • 30:11Nether Neurology Group and I'm going
  • 30:13to give you neurotransmitter 101
  • 30:16for the clinical sleep doctor here,
  • 30:18so you'll have some understanding
  • 30:20of the neurotransmitters involved
  • 30:22in the primary master switch.
  • 30:24If you will.
  • 30:25Of sleep onset depends on on on VLP.
  • 30:28Oh which I'll show in another
  • 30:31slide in the which identifies get
  • 30:34which which is social with GABA.
  • 30:37And the posterior thalamus,
  • 30:38which is closer to the reticular formation,
  • 30:41is how I remember it.
  • 30:43These are the pathways that promote
  • 30:45wakefulness and the wakefulness,
  • 30:47consciousness and REM are mainly
  • 30:49assets you're calling dependent,
  • 30:51but there are contributions from
  • 30:53norepinephrine, glutamate and serotonin.
  • 30:56The basil forebrain involved with
  • 30:59acetal choline poster hypothalamus
  • 31:01system in orexin hypocretin.
  • 31:03It prints the brainstem,
  • 31:05the roster lens, norepinephrine,
  • 31:06dopamine, glutamate, serotonin,
  • 31:07both widespread projections
  • 31:09through the brain,
  • 31:10including the forebrain cortex
  • 31:11reticular activating system, non REM.
  • 31:13Involves Gallup,
  • 31:14GABA, and the VLP.
  • 31:16Oh and the answer hypothalamus,
  • 31:17basal forebrain and there are reciprocal
  • 31:20innovations and REM has at least four
  • 31:22parts which are new to another slide.
  • 31:24So sleepiness away from this relatively
  • 31:27controlled bitonic influences of
  • 31:29these circuits that are dynamic.
  • 31:31Throughout the day and night periods.
  • 31:34Pearls,
  • 31:35fan economy encephalitis lesion
  • 31:36at the junction of the midbrain,
  • 31:39which is looks like a Mickey
  • 31:41Mouse sign and the diencephalon
  • 31:43which is the the thalamus.
  • 31:45And legions of that.
  • 31:50See the VLP oh is very interior car.
  • 31:52That's the master switch as I think of it as
  • 31:56sleep onset a lesion there is
  • 31:58going to cause an unbalanced.
  • 32:02Operation of the wake pathways
  • 32:04which are posterior so involved,
  • 32:07conomo encephalitis,
  • 32:07a lesion of the anterior region,
  • 32:10would cause insomnia,
  • 32:11whereas lesions of the posterior
  • 32:13hypothalamus which these these promote,
  • 32:16wakefulness allow the sleepy
  • 32:18pathways to to take over.
  • 32:20So these are the neural switches that
  • 32:22are that are shut off or turned on,
  • 32:23but it's not like a master switch,
  • 32:25although I put one here.
  • 32:26It's more like cliffs.
  • 32:28Papers work where there is a
  • 32:30a tendency for these pathways
  • 32:33to either be wake promoting or
  • 32:35sleep promoting and then I put
  • 32:38in a very simple cartoon that I
  • 32:40took from a drug package insert
  • 32:42or another package insert.
  • 32:44But about a website.
  • 32:48But simplifies this even further.
  • 32:52Histamine promotes wakefulness
  • 32:53because histamine neurons activate
  • 32:55the cortical subcortical neurons,
  • 32:56including a wake promoting neurons
  • 32:59outside of the hypothalamus.
  • 33:00But it does something quite different.
  • 33:03It modulates and stabilizes the tendency
  • 33:06for the wake circuitry to take over.
  • 33:09The predominant background of.
  • 33:12Of of of. Flow if you will.
  • 33:16I don't know what word to use a of
  • 33:20the activity of the awake pathway.
  • 33:22So, histamine neurons inhibit
  • 33:23the RAM in the non REM sleep,
  • 33:25promoting neurons and prevent
  • 33:27REM intrusion at the wrong time.
  • 33:30And these are the sleep promoting pathways.
  • 33:33So this work really allows us to
  • 33:35think of sleep more as a dial with a
  • 33:39continuum where it's not a binary on off.
  • 33:42There's a tonic continue of awake
  • 33:44and sleep neurobiology based on
  • 33:46the circuitry by these very elegant
  • 33:48diagrams which I use with this team.
  • 33:51From these researchers,
  • 33:52the ram nucleus contains a somewhat of a.
  • 33:55It's like a brain within a brain.
  • 33:57There are four predominant glue
  • 33:59groups of neurons in this.
  • 34:01Core we sub cerulea's nucleus
  • 34:04with is the glutamate ram on.
  • 34:07Circuitry which causes muscle
  • 34:09paralysis and cortical activation.
  • 34:11So you're paralyzed, but someone awake.
  • 34:14The sub cerulea's nucleus
  • 34:16projects to the lateral medulla,
  • 34:18releasing, releasing the GABA.
  • 34:20But it's the this this activation of
  • 34:24that pathway that causes the descending.
  • 34:27Inhibitory neurotransmitter glycine
  • 34:29onto the motor neuron pathways.
  • 34:32Where people are paralyzed by the
  • 34:35reticulospinal tract and the ram
  • 34:37timing is mediated by GABA in the
  • 34:40periaqueductal Gray in the dorsal.
  • 34:42Para gigantis cellular reticular nucleus.
  • 34:45In these regions,
  • 34:46and so the breakdown is that
  • 34:50narcolepsy cataplexy.
  • 34:51Is a inappropriate muscle
  • 34:54paralysis with the xrem on.
  • 34:58Centers activated and REM behavioral
  • 35:00disorders when they are failed
  • 35:02to inhibit that pathway at night.
  • 35:04Leading 2.
  • 35:06Patients acting out their dreams now
  • 35:08disease that involves these accumulations of,
  • 35:11for example,
  • 35:11synucleinopathies and pathology,
  • 35:13such as in the BRAC stages of Parkinson's.
  • 35:16They're sort of infiltrate all this and
  • 35:19caused the REM behavioral disorder,
  • 35:21we think,
  • 35:22but that's beyond the scope of this talk.
  • 35:26Alzheimer's disease is thought to
  • 35:29be ameliorated by.
  • 35:31Increasing.
  • 35:35Sleep continuity an in particularly a small
  • 35:39study involving drug suvorexant showed that.
  • 35:44That the tower in the pathological proteins
  • 35:46in Alzheimer's disease is accumulated
  • 35:48less when there was sleep promotion.
  • 35:50I don't believe there's any neurobiology
  • 35:52indicated these patients with primary
  • 35:54hypersomnia have less Alzheimer's,
  • 35:56and I'm not indicating that's the case.
  • 35:59I'm just merely raising the question.
  • 36:02So cataplexy, we think occurs when those rim
  • 36:05centers activating this muscle paralysis,
  • 36:07and there's evidence that cataplexy
  • 36:09is instituted from an emotional
  • 36:11stimulus from the right amygdala,
  • 36:13in particularly that acts on
  • 36:15the sub cerulea's nucleus,
  • 36:16and causes that paralysis.
  • 36:19So we wake promoting agents and the
  • 36:22sleep promoting age is the newer
  • 36:24one which will get too involved.
  • 36:26These other neurotransmitters,
  • 36:28the H3 receptors have effect on
  • 36:30excessive daytime sleepiness,
  • 36:31particularly some of the newer agents.
  • 36:33The one newer agent that I know of that's
  • 36:36approved it causes an increase in the
  • 36:40presynaptic histamine availability,
  • 36:41causing you to be have more neurotransmitter
  • 36:44transmitters and keep you awake more.
  • 36:49So. This sleep fragmentation, though,
  • 36:52is not unique to narcoleptics and and
  • 36:54patients with primary sleep instability.
  • 36:57An elderly person also may have a
  • 37:00similar hypnogram to some some of our
  • 37:04medical residents that are up at night.
  • 37:07I'm call sleep will look like.
  • 37:10Like this, we often don't do a
  • 37:13daytime MSL T in our in our cohorts.
  • 37:16Of these, these types of individuals,
  • 37:18but we wonder if sleep intrusion
  • 37:20would also occur.
  • 37:21So our testing is never diagnostic
  • 37:23unless you get a hypo cretin level,
  • 37:25or you can actually visualize what
  • 37:28part of the sleep Wake pathway.
  • 37:30Anatomically. Is involved, so we use MSLT.
  • 37:35The multiple sleep latency test
  • 37:37versus the MSLMLMWT as a surrogate
  • 37:40marker as to how sleepy they are
  • 37:43and we accept this based on these
  • 37:46papers from around 20 plus years ago.
  • 37:49This is from the ASM website Twenty 05.
  • 37:54Anne.
  • 37:54These patients with narcolepsy have
  • 37:56to have a mean sleep latency of
  • 37:59less than eight with two sirens.
  • 38:02Anything else?
  • 38:03Once I went,
  • 38:04no sound is idiopathic hypersomnia.
  • 38:06And if you don't have a decreased
  • 38:08mean sleep latency in that level,
  • 38:10it's debatable whether or not
  • 38:11you actually have.
  • 38:12Pathological sleepiness to that degree,
  • 38:14but MSL TMWT is a marker of degrees
  • 38:17of sleepiness that's supportive or
  • 38:20maybe supportive under the right
  • 38:22circumstances of particularly narcolepsy.
  • 38:25We are not able to assess ourselves when
  • 38:28we are having excessive daytime sleepiness,
  • 38:32we cannot access our assess ourselves.
  • 38:34Sometimes when we have seizures.
  • 38:38In particularly as we give a talk to our
  • 38:42residents when they come in on safety,
  • 38:45there are more errors and residents
  • 38:47may almost reprobate Epworth
  • 38:49score in the narcoleptic range,
  • 38:51but even brief naps may promote alertness,
  • 38:54but nothing substitute for sleep.
  • 38:57Other than sleep.
  • 38:59Idiopathic hypersomnia is
  • 39:02an entity which we end up.
  • 39:04Seeing a lot of these patients
  • 39:06who come to us who do not meet the
  • 39:09criteria for narcolepsy on testing
  • 39:11and it's a management problem
  • 39:13because pharmacotherapy is often
  • 39:15off label for these individuals,
  • 39:17or confined to PROVIGIL.
  • 39:18NUVIGIL which the society ASM
  • 39:20practice standards indicate may
  • 39:22be options for those patients.
  • 39:24But type one narcolepsy.
  • 39:25There's there's all these features,
  • 39:27with the exception of sleep drunkenness,
  • 39:30which is very prominent.
  • 39:31Idiopathic hypersomnia.
  • 39:32There's no cataplexy in narcolepsy,
  • 39:34two or IH.
  • 39:37An naps a very refreshing and narcolepsy
  • 39:40one sometimes not into, but rarely if at all.
  • 39:43In IH.
  • 39:45So these are.
  • 39:47Some of the.
  • 39:52The Coop so Coco Curring percentages
  • 39:55of cataplexy in narcolepsy.
  • 39:57Up to 50% triggered by emotionally
  • 40:00triggered things in sleep paralysis
  • 40:02occurs in about 4080% of these patients,
  • 40:06along with the hypnopompic
  • 40:09hallucinations. The.
  • 40:13Pathologic mechanism is thought to be the
  • 40:15deficiency of the hypocretin mechanism
  • 40:17and signaling caused by selective loss
  • 40:19of hypocretin producing neurons in the
  • 40:21hypothalamus and it may be autoimmune.
  • 40:23There's a clinical trial for those
  • 40:26that have post traumatic type of.
  • 40:28I've narcolepsy.
  • 40:29I tried to publish a case years
  • 40:31ago and was rejected summarily
  • 40:33by many different channels.
  • 40:35'cause it was like an evidence it's good
  • 40:37to see that that constant may be emerging,
  • 40:40but genetic factors which
  • 40:43involved the QB one.
  • 40:45Star 0602 are involved in the header dimer
  • 40:48which may be dysfunctional along with
  • 40:52environmental factors that contributed
  • 40:54to the development occurrence of these.
  • 40:58Semiologie, zven T1 and T2.
  • 41:02This I took from the
  • 41:05Internet from an article.
  • 41:07Showing that the selective
  • 41:09loss of hypocretin erection.
  • 41:11In these areas around the third ventricle.
  • 41:14A comic. From the.
  • 41:17Tetrad of narcolepsy.
  • 41:21The DSM Diagnostic Statistical Manual
  • 41:245 allows you to define narcolepsy.
  • 41:28Cataplexy, as long as his recurrent
  • 41:31episodes of irrepressible need to sleep.
  • 41:33Occurring at least three times
  • 41:35a week over three months,
  • 41:37but there needs to be one of these entities,
  • 41:40such as cataplexy,
  • 41:41hypocretin deficiency,
  • 41:42and a positive.
  • 41:44Quite diagnostic on label and SLT.
  • 41:48I been sleep rating RAM latency in
  • 41:50less than 15 minutes increase seating.
  • 41:52Polysomnogram is also helpful.
  • 41:54There are many decision making
  • 41:56algorithms that are in the
  • 41:57literature on what to do if you.
  • 41:59Have a patient that doesn't quite
  • 42:01satisfy that MSL T criteria.
  • 42:04Well,
  • 42:04some of these slides come from
  • 42:06studies of residual sleepiness that
  • 42:09may be based on industry where
  • 42:11a market was created to give a
  • 42:14drug after patients are treated
  • 42:16with CPAP for treatment of OSA.
  • 42:18But the neurobiology which is.
  • 42:21Runs comment all these types of studies that.
  • 42:24There is deep Gray and white
  • 42:27matter problems changes in DWI,
  • 42:29DTI diffusion, weighted not diffusion,
  • 42:32tensor imaging as well as loss
  • 42:35of of bold signal coupling.
  • 42:38In many of these.
  • 42:41Areas where I showed you slides about
  • 42:44typically in the brainstem RAM areas,
  • 42:47reticular activating systems
  • 42:48and their projections,
  • 42:50so the extrapolation is involved,
  • 42:52that there is degeneration,
  • 42:54arousal,
  • 42:55neurons,
  • 42:55and chronic sleep disruption
  • 42:57for these residual patients
  • 42:59with residual sleep apnea as a.
  • 43:02As a as a form of verifying their
  • 43:05complaint and looking for a treatment for it,
  • 43:08and you can find these all over the Internet.
  • 43:12There is a form of idiopathic hypersomnia.
  • 43:17That has long sleep time and
  • 43:19particularly long sleep time.
  • 43:20It's weekly associated with evening
  • 43:22chronotypes and young age, and it's not
  • 43:24adequately diagnosed using the Ms Lt.
  • 43:26Perhaps because it's time drunk.
  • 43:29But we need to analyze these
  • 43:32patients further. Unfortunately,
  • 43:33this is the list of FDA approved,
  • 43:36approved, indicated drugs and
  • 43:38therapies for idiopathic hypersomnia.
  • 43:39You see him there aren't any.
  • 43:42It's very frustrating.
  • 43:44Uhm? If you go on the.
  • 43:48Internet you can find all the new drugs that
  • 43:51are approved and the older drugs are there.
  • 43:55There's only only sodium oxybate is
  • 43:57approved as an anti cataplex tick.
  • 44:00Uhm? In idiopathic hypersomnia,
  • 44:04the symptoms are quite.
  • 44:07Disabling these are hypersomnia
  • 44:09complaints at their worst, brain fog,
  • 44:11poor memory you need for multiple alarms,
  • 44:14intentional naps and non
  • 44:15refreshing with daily launch sleep.
  • 44:17In many of these patients
  • 44:20that have long sleep time.
  • 44:22And comparing. Uhm?
  • 44:27Longer sleep time too.
  • 44:28Those without long sleep time you can
  • 44:31see that the long sleep time patients
  • 44:33have fireworks pathology subjectively
  • 44:35and none of these are in the diagnostic
  • 44:38criteria for making a diagnosis hypersomnia.
  • 44:41Uhm?
  • 44:43These are the current.
  • 44:47Trials available in studies that
  • 44:50are on the hypersomnia.org website.
  • 44:52And there are some new studies
  • 44:55looking at Tak 925 which is
  • 44:57an erection Type 2 receptor.
  • 45:00Agonist in patients with narcolepsy Type 1.
  • 45:04There was, there was.
  • 45:06A study with Modafinil for
  • 45:08idiopathic hypersomnia,
  • 45:09which seems to improve it but
  • 45:11doesn't mitigate safety risks.
  • 45:15There are some studies looking there's
  • 45:17a study looking at sodium oxybate.
  • 45:19Pretty pathic hypersomnia
  • 45:20compared to patients narcolepsy
  • 45:22which may have some benefit.
  • 45:24All this is off label. Not advocating.
  • 45:27I'm just describing clarithromycin.
  • 45:28May provide some benefit.
  • 45:30It was a trial.
  • 45:31There's a trial of stimulation.
  • 45:35Which I believe was shut down to the meeting.
  • 45:38Lack of meeting primary
  • 45:39endpoints and or funding.
  • 45:40Levothyroxine and idiopathic hypersomnia,
  • 45:41with long sleep time may
  • 45:43be somewhat beneficial,
  • 45:44but I don't think these are our fabricated,
  • 45:46but they are mentioned in
  • 45:49an evolving literature.
  • 45:50I put up the practice parameters
  • 45:52for the treatment of narcolepsy
  • 45:53and hypersomnia is from our
  • 45:55twenty 07 morganthaler paper and
  • 45:57these are just the high points.
  • 45:59There's drugs on there that aren't
  • 46:00even available, such as root answering,
  • 46:03which I believe was only used
  • 46:05as a research drug.
  • 46:07But we're left with all the older drugs here.
  • 46:09The newer ones are not here yet.
  • 46:12Perhaps in the updated practice
  • 46:14parameters they will be.
  • 46:15A need for peer reviewed literature
  • 46:19involving special populations.
  • 46:21Is it knowledge?
  • 46:22And in this slide from that era,
  • 46:24sodium oxybate for examples,
  • 46:25categories categorized as a Schedule B.
  • 46:27Right now it's it's.
  • 46:28It's thought to be cause harm,
  • 46:30but doesn't have a definite I believe.
  • 46:33And then.
  • 46:35Thinking of the new.
  • 46:37Drugs that are out there to send versus soul,
  • 46:40solar and fettle which are.
  • 46:42Wake promoting agents.
  • 46:44One being a H3 receptor antagonist.
  • 46:48Soul reaffirm federal.
  • 46:51Can cause cutey changes,
  • 46:53insomnia,
  • 46:53nausea, anxiety.
  • 46:54It's going to just metabolise
  • 46:57oral contraceptives and
  • 46:59anticoagulants potentially.
  • 47:02Limited in hepatic and renal
  • 47:04conditions and the half-life.
  • 47:06Or or maybe up to 20 hours.
  • 47:09This one is not a controlled.
  • 47:11The Mrs Patel assigned on the left on
  • 47:14the right so knows these are scheduled
  • 47:164 which is a dopamine norepinephrine.
  • 47:19Meaning DNR I which has reduced
  • 47:21or no interaction with ocps.
  • 47:23It's also has the indication
  • 47:25for residual sleepiness and OSA.
  • 47:27If you've had it more than a month,
  • 47:30it's half life is about 7 hours.
  • 47:33So how do we evaluate our initial case?
  • 47:36We do a careful history of
  • 47:38physical looking for all the
  • 47:40secondary causes that we can treat.
  • 47:42We want to make sure that there aren't
  • 47:45any environmental or other causes
  • 47:47we want to do a supportive proof of
  • 47:49pathology through an MSL team ornament WT.
  • 47:52We want to make sure we
  • 47:54inventory the environment.
  • 47:55The behavioral aspects of the case.
  • 47:58Do it as much supportive testing if we can.
  • 48:01In the past we had a problem getting
  • 48:03the hypocretin levels in the CSF,
  • 48:04so I'm calling about.
  • 48:05I don't want to say about 8 to 10 years
  • 48:08of not being able to get a CSF hypocretin.
  • 48:11Apparently it's now available
  • 48:12at the male clinic.
  • 48:14We want to treat the excessive
  • 48:16daytime sleepiness complaint in
  • 48:17these patients and particularly.
  • 48:19As much of the athletes symptoms as possible,
  • 48:22we schedule naps to give
  • 48:23them refreshing apps,
  • 48:24especially if they have not collected Type 1.
  • 48:28We give them stimulants,
  • 48:29we give them tricyclics and SSR
  • 48:31eyes to inhibit the rim nucleus
  • 48:33type of descending pathways onto
  • 48:35the motor tracts and we treat any
  • 48:37disorder in the evening or otherwise
  • 48:39that fragment sleep that can lead
  • 48:41to EDS that can trigger attacks.
  • 48:43'cause these patients are ready at the
  • 48:45get go to have rim or sleeping continents
  • 48:48in an inappropriate time during the day.
  • 48:51So with our initial case are 22 year old
  • 48:54we excluded other causes of sleepiness.
  • 48:56We. Finding normal polysomnogram
  • 48:58we found a very diagnostic MSL T
  • 49:01with sorum's and sleep incontinence
  • 49:03REM incontinence during the day
  • 49:05and we treated with wake promoting
  • 49:07agents Modafinil than armodafinil,
  • 49:09which is a slightly longer half life.
  • 49:12And the patients to contain
  • 49:14complained of cataplexy,
  • 49:15which may often not be recognized.
  • 49:18These patients also are somewhat reclusive.
  • 49:20They're afraid of social interaction,
  • 49:22and there also have an adverse aerial
  • 49:25relationship with many of their doctors
  • 49:27because they asked basically for them.
  • 49:30From them,
  • 49:30these controlled substances which leads
  • 49:32to all sorts of of tough adverse aerial
  • 49:35head-to-head interactions in the office.
  • 49:37So these patients often don't
  • 49:39volunteer the full plate of their
  • 49:41existence was not only do they fail
  • 49:43to be believed by multiple providers,
  • 49:46they lack faith that it will be recognized.
  • 49:49So it took some controlling to get
  • 49:52to the hypnagogic phenomena patient,
  • 49:54really thought that they were going to
  • 49:56be diagnosed with a mental disorder,
  • 49:59but.
  • 49:59When we preempted by telling them that we
  • 50:02expect you probably have this and maybe
  • 50:05you didn't mention to us they opened
  • 50:08right up an SSRI emulated those systems.
  • 50:10So we want to recognize all the subtle
  • 50:13manifestations of these types of
  • 50:15disorders and truly advocate for this
  • 50:17niche of patients that may be truly
  • 50:20reclusive and somewhat marginalized
  • 50:21from mainstream medical care.
  • 50:24In particularly,
  • 50:25these young patients with hypersomnia
  • 50:27idiopathic hypersomnia after ASM last year,
  • 50:29I wanted to study a cohort of these
  • 50:32and these patients who have idiopathic
  • 50:35hypersomnia and narcolepsy not group.
  • 50:38There.
  • 50:40Waso time rivals that of.
  • 50:43Mild, moderate OSA.
  • 50:47And this data is still being analyzed
  • 50:49in under analysis for to be presented
  • 50:52the ASM in a couple of weeks.
  • 50:54So on that note,
  • 50:55I want to close.
  • 50:56I want us all to recognize these patients.
  • 50:59There is a well developed neurobiology
  • 51:02that's being understood by some very.
  • 51:04Detailed.
  • 51:07Neurobiology that is well beyond the
  • 51:09scope and breadth of Emir clinician
  • 51:11like myself and so I I site and cut
  • 51:14and pasted these with the steam.
  • 51:16These state of the art for idio
  • 51:18hypersomnia is an evolution.
  • 51:20And at this point I'll conclude and openly.
  • 51:24Remaining part of the talk to discussion.
  • 51:30Great, well thank you.
  • 51:31Thank you very much like roster
  • 51:33and appreciate a wonderful talk
  • 51:35and thanks for a nice overview of
  • 51:37sleepiness and the general population
  • 51:39through the ages as well as the
  • 51:43various causes of hypersomnia.
  • 51:45And sort of thinking of things that we
  • 51:47beyond what you think about his sleep clinic.
  • 51:50I've seen in the past couple Sonia
  • 51:52and so I have a question.
  • 51:55I was hoping you could help us with and
  • 51:58I see there's also a few in the chat,
  • 52:01so in your experience of treating
  • 52:03these patients other particular
  • 52:05drugs that tend to work better for
  • 52:07a specific cause of hypersomnia,
  • 52:08so idiopathic Arbor summer Snorkel FC
  • 52:10versus that that may perhaps be residual
  • 52:13in somebody who has chronic epilepsy.
  • 52:16It's a very good question.
  • 52:17Recently this came up and we
  • 52:19actually went outside our center
  • 52:20to pull someone at another center.
  • 52:22It's very difficult to tell
  • 52:24because a lot of the stimulants.
  • 52:27Provoke epileptiform discharges.
  • 52:28It's felt without a lot of without
  • 52:32a lot of authoritative evidence that
  • 52:34may be Modafinil and armodafinil.
  • 52:37Might be the safest.
  • 52:39But there's little authoritative
  • 52:41literature on what to do,
  • 52:43which presents a problem.
  • 52:45We always want to be on label and you know,
  • 52:49we at the same time.
  • 52:52With these conditions.
  • 52:53There's a real potential to induce seizures,
  • 52:57even in the.
  • 53:00General population for drugs such as well
  • 53:02buitron which is treating depression.
  • 53:04So there is some cortical excitability,
  • 53:07but what to do authoritatively?
  • 53:09Is we generally start.
  • 53:12These noncardiac talks and not noncardiac
  • 53:15talks stimulants in young patients
  • 53:17in particular because they have a
  • 53:19whole trajectory of life ahead of them,
  • 53:22so we generally don't reach
  • 53:24for Dexedrine spansule's.
  • 53:25Also, there's an addiction potential.
  • 53:28We try to use drugs that have
  • 53:31a smoother but lower peak.
  • 53:34Type of. PK,
  • 53:36which may mitigate sleepiness longer but not.
  • 53:40Cars addiction and may not cause
  • 53:42cortical irritability, but this is.
  • 53:45Not authoritative,
  • 53:46but there's little neurobiology and
  • 53:48research that verifies it's very complicated,
  • 53:50so the weird guy that looks at squiggles,
  • 53:53I mean me, the epileptologist.
  • 53:54The neurologist usually gets these
  • 53:57patients in the sleep clinic.
  • 53:59It's very tough.
  • 54:00We try to advocate and help,
  • 54:02but we are bound by.
  • 54:04The forces of our lack of understanding.
  • 54:08Thank you, thank you very much,
  • 54:11Doctor Robert Thomas from Beth Israel,
  • 54:13lifting and then no new biology of sleep,
  • 54:16wake, explain, or even perhaps we
  • 54:18can speculate on the long sleep or
  • 54:21hypersomnia seasonal affective disorder,
  • 54:23bipolar and depression. In short,
  • 54:25no sleep with bipolar and mania.
  • 54:29It's really interesting and
  • 54:30then the obverse or the inverse.
  • 54:32With client 11 you know that.
  • 54:35What pathways what?
  • 54:36Parallel pathways what part of the
  • 54:39pathways are involved not involved?
  • 54:42Are yet to be figured out we.
  • 54:44Really still don't understand a lot of these.
  • 54:48Diseases, processes, conditions.
  • 54:51Very deep. Question of which I hope.
  • 54:56As we do more research.
  • 54:58You can answer.
  • 54:59I don't know if anyone else has it better.
  • 55:02Understanding about.
  • 55:06You know what is? Idiopathic hypersomnia
  • 55:09we have a normal hypocretin level or or
  • 55:12a third or greater than 1/3 of normal,
  • 55:14but no cataplexy. What part of the
  • 55:16pathway mediates that, if at all?
  • 55:18Or is it a completely separate entity?
  • 55:20I just. You just don't know
  • 55:22and then how do you treat it?
  • 55:24Because there are no.
  • 55:25Or I'm legal drugs for that?
  • 55:27Will you do so we push?
  • 55:30Treating this comorbid psychiatric
  • 55:32conditions and behavioral therapy,
  • 55:33we ally, fortunately enough,
  • 55:35with a very quick cognitive behavioral.
  • 55:38Provider who saves the day.
  • 55:40Many of the times because often these
  • 55:42young patients with hypersomnia they have a
  • 55:45very significant phase delay and they are.
  • 55:48Propagating that and they have self
  • 55:51propagating factors of precipita
  • 55:53or perpetuating factors of.
  • 55:55Of sleep dysfunction.
  • 55:57Insomnia, commingled with these disorders.
  • 55:59So the borderland between
  • 56:01psychiatry and neurology.
  • 56:02I,
  • 56:03I think about Mccarley and what he stood for,
  • 56:07although his adenosine pathway doesn't
  • 56:09quite have relevance in industry and
  • 56:11maybe an effort epiphenomenon, but it's.
  • 56:14It's a marker of something
  • 56:15we have yet to understand,
  • 56:18so that was a very rambly,
  • 56:19long winded answer to that
  • 56:20question or lack of.
  • 56:24I am and so I think we have time for just
  • 56:27one more and there is a related
  • 56:31question to intersection two in
  • 56:33psychiatric disorders and hypersomnia
  • 56:35and is there any relationship between
  • 56:39psychosis and hypersomnia? Well,
  • 56:42yes, I believe. William Dimension Stanford
  • 56:47pioneered those studies years ago.
  • 56:51I don't want to misspeak, but I remember.
  • 56:57When they took graduate students and.
  • 57:00Sweet deprive them, and they did. You know?
  • 57:05Persistence of wakefulness tests in
  • 57:07their site. Piper reaction time,
  • 57:11but if you really sleep deprived someone
  • 57:14you can produce an affective psychosis so.
  • 57:17Where does the circuitry? For that.
  • 57:22Coming on these pathways in the
  • 57:23frontal lobes, we don't know.
  • 57:26Takeover become unleashed.
  • 57:27Where does the neurobiology of of.
  • 57:30From having a normal sleep wake period
  • 57:33to one that sleep deprived where you
  • 57:35become like fatal familial insomnia.
  • 57:38These patients.
  • 57:39Profoundly deranged and I don't know about.
  • 57:43More appropriate medical term,
  • 57:44but they the more sleep deprived
  • 57:46you are chronically,
  • 57:47the more tendency for psychosis do is,
  • 57:49I think that's accepted.
  • 57:52That's why this area is so fascinating.
  • 57:54Maybe 50 years from now.
  • 57:56Some other condition.
  • 57:57It is very demanding.
  • 57:58Patients will have answer.
  • 58:01Great, well thank you.
  • 58:02Thank you for a wonderful talk
  • 58:04and for giving us a chance to
  • 58:06think about hypersomnia and a
  • 58:08little bit of a different way.
  • 58:10They were traditionally approach
  • 58:11it and so with this I'd like to
  • 58:14close the conference and say that
  • 58:15this is our last joint yell sleep.
  • 58:18Harvard Tufts Seminar will
  • 58:19resume our meetings next fall
  • 58:20this coming fall in September.
  • 58:22And then we still have a couple
  • 58:24of meetings left for the Yale
  • 58:26regularly seminars that occur
  • 58:27at 2:00 o'clock on Wednesdays.
  • 58:29And so if you do wish to receive CME credit,
  • 58:32please go ahead and text the code.
  • 58:36To the CME number,
  • 58:37and we look forward to seeing you
  • 58:39guys again in the next Wednesday.
  • 58:42Take care everybody thank you.
  • 58:43Bye bye.